Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
XYMOGEN history
XYMOGEN company history timeline
In October of 2003, the nutraceutical company XYMOGEN was created.
In 2003 he researched, developed and launched the XYMOGEN line of professional formulas.
Partnership with Doctor David Perlmutter, FACN, ABIHMIn February 2010, XYMOGEN acquired Doctor David Perlmutter’s iNutritionals line of neurological formulas.
The company has repeatedly outgrown offices, necessitating the construction in 2012 of a new, state-of-the-art manufacturing facility.
XYMOGEN joined the “Honor Roll Alumni” in 2012, which is the elite group of companies who have made the list at least five times.
CleanSeas, which was launched in February of 2017, aims to target the causes of marine litter by limiting the production and consumption of non-recoverable and single-use plastic such as bottles, bags, and straws.
These numbers follow 14 straight years of double-digit revenue gains reached prior to 2019.
WholeScripts Pharmacy, LLC – our online, truly integrated pharmacy, which opened for business in March 2021, and is the only one that combines exclusive XYMOGEN formulas with prescription medications in convenient daily dose packs.
XYMOGEN sales increased 6.4% to $128.43 million in 2021 up from the $120.67 million posted last year.
At a time when few companies are growing, as of March 31, 2022, XYMOGEN has grown revenues for 69 quarters and has realized over 100 percent growth in the past five years.
Rate XYMOGEN's efforts to communicate its history to employees.
XYMOGEN jobs
Do you work at XYMOGEN?
Does XYMOGEN communicate its history to new hires?
XYMOGEN competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Designs for Health | 1989 | $500,000 | 50 | - |
| Standard Process | 1929 | $4.4M | 200 | 20 |
| Metagenics | 1983 | $297.5M | 150 | 28 |
| Ortho Molecular Products | 1989 | $15.1M | 50 | 6 |
| C.B. Fleet | 1869 | $200.0M | 750 | - |
| CooperVision | 1958 | $1.1B | 25 | 8 |
| Neogen | 1982 | $924.2M | 1,764 | 104 |
| Novel Ingredients | 1995 | $6.3M | 75 | - |
| Pharmachem Laboratories | 1979 | $132.4M | 127 | - |
| Enzymedica | 1998 | $182.0M | 20 | 2 |
XYMOGEN history FAQs
Zippia gives an in-depth look into the details of XYMOGEN, including salaries, political affiliations, employee data, and more, in order to inform job seekers about XYMOGEN. The employee data is based on information from people who have self-reported their past or current employments at XYMOGEN. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by XYMOGEN. The data presented on this page does not represent the view of XYMOGEN and its employees or that of Zippia.
XYMOGEN may also be known as or be related to XYMOGEN, XYMOGEN, INC., XYMOGEN, Inc, XYMOGEN, Inc., Xymogen and Xymogen, Inc.